Varsha Gandhi

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 11

Top Venues

The University of Texas MD Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas MD Anderson Cancer Center

United States

Professor & Chair ad interim :: Experimental Therapeutics

Publications

Burcu Aslan, Ganiraju Manyam, Lakesla R Iles, Shady Ibrahim Tantawy, Sai Prasad Desikan, William G Wierda, Varsha Gandhi
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib. Blood advances 8 (17) (2024)
Burcu Aslan, Ganiraju Manyam, Lakesla R Iles, Shady Ibrahim Tantawy, Sai Prasad Desikan, William G Wierda, Varsha Gandhi
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib. Blood advances 8 (17) (2024)
Burcu Aslan, Gorkem Kismali, Lakesla R Iles, Ganiraju C Manyam, Mary L Ayres, Lisa S Chen, Mihai Gagea, Maria Teresa Sabrina Bertilaccio, William G Wierda, Varsha Gandhi
Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia. Blood cancer journal 12 (5) (2022)
Shady Ibrahim Tantawy, Aloke Sarkar, Stefan E Hubner, Zhi Tan, William G Wierda, Abdelraouf Eldeib, Shuxing Zhang, Steven Mitchell Kornblau, Varsha Gandhi
Mechanisms of MCL-1 protein stability induced by MCL-1 antagonists in B-cell malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Natalia Timofeeva, Varsha Gandhi
Ibrutinib combinations in CLL therapy: scientific rationale and clinical results. Blood cancer journal 11 (4) (2021)
Prithviraj Bose, Varsha Gandhi
Managing chronic lymphocytic leukemia in 2020: an update on recent clinical advances with a focus on BTK and BCL-2 inhibitors. Faculty reviews 10 (2021)
Nitin Jain, Phillip A Thompson, Jan A Burger, Alessandra Ferrajoli, Koichi Takahashi, Zeev E Estrov, Gautam Borthakur, Prithviraj Bose, Tapan Mahendra Kadia, Naveen Pemmaraju, Koiji Sasaki, Marina Y Konopleva, Elias J Jabbour, Naveen Garg, Xuemei Wang, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Wei Wang, Jeffrey Jorgensen, Sa Wang, Wanda Lopez, Ana Ayala, William Plunkett, Varsha Gandhi, Hagop M Kantarjian, Susan O'Brien, Michael Keating, William G Wierda
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35 (12) (2021)
Aloke Sarkar, Varsha Gandhi
Activation of ATM kinase by ROS generated during ionophore-induced mitophagy in human T and B cell malignancies. Molecular and cellular biochemistry 476 (1) (2020)
Prithviraj Bose, Lisa S Chen, Varsha Gandhi
Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the 'real world'. Leukemia & lymphoma 60 (7) (2019)
Christine M Stellrecht, Lisa S Chen, Mary L Ayres, Jennifer B Dennison, Shujun Shentu, Yuling Chen, Michael J Keating, William G Wierda, Varsha Gandhi
Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapy. British journal of haematology 179 (2) (2017)
Prithviraj Bose, Varsha Gandhi
Recent therapeutic advances in chronic lymphocytic leukemia. F1000Research 6 (2017)
Amal A El-Mabhouh, Mary L Ayres, Elizabeth J Shpall, Veerabhadran Baladandayuthapani, Michael J Keating, William G Wierda, Varsha Gandhi
Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells. Blood 123 (24) (2014)

Varsha Gandhi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Varsha Gandhi